XBiotech (XBIT) Operating Expenses (2014 - 2026)
XBiotech (XBIT) recorded Operating Expenses of $6.15 million in Q2 2026, down 3.0% from $6.34 million a year earlier.
Powered by 
Analysis
XBiotech (XBIT) Operating Expenses (2014 - 2026) Analysis & Trends
On a TTM basis, XBiotech's Operating Expenses came in at $48.28 million as of Jun 30, 2026, up 32.1% year-over-year; for FY2025, it was $55.69 million, up 31.1% from FY2024.
- Annual Operating Expenses has a five-year compound annual growth rate of 15.0% (FY2020 to FY2025).
- Across earlier years, Operating Expenses came in at $42.47 million in FY2024 (+13.2%), $37.51 million in FY2023 (-0.9%), $37.85 million in FY2022 (+0.5%) and $37.66 million in FY2021 (+35.8%).
- Quarterly Operating Expenses has ranged from $6.05 million in Q3 2025 to $29.76 million in Q4 2025 over the past five years.
- On a year-over-year basis, Operating Expenses rose in three of the last seven quarters, with growth averaging 25.1%.
- Peak year-over-year performance for Operating Expenses in the last five years was growth of 240.1% in Q4 2025, against a decline of 57.7% in Q2 2025 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 10.12 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 10.56 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 12.80 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -6.09 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -9.70 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 6.54 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 18.20 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 6.68 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 2.09 Bn |
| 10 | XBiotech | 65.55 Mn | 65.55 Mn | - | 6.15 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.15 Mn |
| Dec 31, 2025 | 29.76 Mn |
| Sep 30, 2025 | 6.05 Mn |
| Jun 30, 2025 | 6.34 Mn |
| Mar 31, 2025 | 13.55 Mn |
| Dec 31, 2024 | 8.75 Mn |
| Sep 30, 2024 | 7.90 Mn |
| Jun 30, 2024 | 14.97 Mn |
| Mar 31, 2024 | 10.85 Mn |
| Dec 31, 2023 | 8.59 Mn |
| Sep 30, 2023 | 8.52 Mn |
| Jun 30, 2023 | 13.26 Mn |
| Mar 31, 2023 | 7.15 Mn |
| Dec 31, 2022 | 8.45 Mn |
| Sep 30, 2022 | 7.85 Mn |
| Jun 30, 2022 | 13.42 Mn |
| Mar 31, 2022 | 8.13 Mn |
| Dec 31, 2021 | 10.65 Mn |
| Sep 30, 2021 | 7.14 Mn |
| Jun 30, 2021 | 13.77 Mn |
API Access
XBiotech Operating Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-expenses&ticker=XBIT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-expenses", "ticker": "XBIT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-expenses&ticker=XBIT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();